AI and the False Claims Act - JD Supra
There’s always a “but” when it comes to AI. It has great potential, but there’s always the risk of bad things happening. In the case of the False Claims Act and healthcare, that’s very much the case.
Investor protection firm Kaskela Law LLC announces that is investigating Take-Two Interactive Software, Inc. ("Take-Two") (NASDAQ: TTWO) on behalf of the company's stockholders.
On January 10, 2022, Take-Two announced that it had entered into a definitive agreement to acquire Zynga in a cash and stock transaction valued at $9.86 per Zynga share, with a total enterprise value of approximately $12.7 billion. According to the announcement, Take-Two is expected to issue between 50.3 million - 58.5 million shares of Take-Two stock to Zynga stockholders who are, as a result, expected to own between 29.6% - 32.8% of the combined company.
The investigation seeks to determine whether the members of Take-Two's Board of Directors violated the securities laws or breached their fiduciary duties to TTWO shareholders in connection with the proposed transaction, and whether Take-Two shareholders are being provided with all material information in connection with the proposed merger.
Take-Two shareholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 - 0750, or by email ([email protected]) or online at https://kaskelalaw.com/cases/take-two/, for additional information about this investigation and their legal rights and options.
Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.
CONTACT:
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 - 0750
(888) 715 - 1740
www.kaskelalaw.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/115044
There’s always a “but” when it comes to AI. It has great potential, but there’s always the risk of bad things happening. In the case of the False Claims Act and healthcare, that’s very much the case.